Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

181371 Press Releases
DateTitleCompany
09 Jul 09 Japanese Ministry of Health approves Rasilez®, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure Novartis,
Published by
PharmiWeb.com
09 Jul 09 New Drug Application for Exenatide Once Weekly Accepted for Review by FDA Lilly,
Published by
PharmiWeb.com
09 Jul 09 King Provides Additional Information on the REMOXY® NDA Resubmission Plan King Pharmaceuticals,
Published by
PharmiWeb.com
09 Jul 09 ENBREL to Add Indication of Juvenile Idiopathic Arthritis (JIA) Takeda,
Published by
PharmiWeb.com
09 Jul 09 Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases GlaxoSmithKline,
Published by
PharmiWeb.com
09 Jul 09 AstraZeneca to Advance AZD3480 in ADHD AstraZeneca,
Published by
PharmiWeb.com
08 Jul 09 Japanese Ministry of Health approves Rasilez®, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure Novartis,
Published by
PharmiWeb.com
08 Jul 09 New Drug Application for Exenatide Once Weekly Accepted for Review by FDA Eli Lilly,
Published by
PharmiWeb.com
08 Jul 09 Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 First Quarter Earnings Forest Laboratories, Inc,
Published by
PharmiWeb.com
08 Jul 09 Shire has filed a treatment protocol for velaglucerase alfa for Gaucher Disease Shire,
Published by
PharmiWeb.com
08 Jul 09 Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results Johnson & Johnson,
Published by
PharmiWeb.com
08 Jul 09 Lundbeck increases its share of Xenazine® and strengthens the U.S. profitability - transaction immediately accretive Lundbeck,
Published by
PharmiWeb.com
08 Jul 09 Allergan Announces Quarterly Conference Call Allergan,
Published by
PharmiWeb.com
08 Jul 09 ENBREL to Add Indication of Juvenile Idiopathic Arthritis (JIA) TAKEDA,
Published by
PharmiWeb.com
08 Jul 09 Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases AMGEN,
Published by
PharmiWeb.com
08 Jul 09 Landmark study for GSK’s cervical cancer vaccine published in The Lancet GlaxoSmithKline,
Published by
PharmiWeb.com
08 Jul 09 Teva Provides Update On Generic Ortho Tri-Cyclen® Lo Teva,
Published by
PharmiWeb.com
07 Jul 09 CBP501 Enters Phase II Trials for the Treatment of Non-Small Cell Lung Cancer Takeda,
Published by
PharmiWeb.com
06 Jul 09 Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology Johnson & Johnson,
Published by
PharmiWeb.com
06 Jul 09 Quotient Clinical Receives MHRA Supplementary Accreditation Quotient Clinical,
Published by
The Scott Partnership
07 Jul 09 European Commission approves statement on lipid improvement for Viramune® label Boehringer Ingelheim ,
Published by
PharmiWeb.com
07 Jul 09 New Online Resource Launches For Patients With Chronic Myeloid Leukemia Bristol-Myers Squibb,
Published by
PharmiWeb.com
03 Jul 09 Successful Investigational New Drug application (IND) Review for Intravenous CP-4126 Clavis Pharma ,
Published by
PharmiWeb.com
06 Jul 09 Novartis delivers 250,000,000th Coartem® treatment and becomes first healthcare company to join United Against Malaria partnership Novartis, ,
Published by
PharmiWeb.com
06 Jul 09 2009/042 NICE announces review of its skin cancer guidance NICE,
Published by
PharmiWeb.com
06 Jul 09 Takeda to hold the commencement ceremony for Construction of Takeda,
Published by
PharmiWeb.com
06 Jul 09 Eisai to Initiate Clinical Trial of Dacogen® in Pediatric Patients with Acute Myelogenous Leukemia in the US Eisai Co., Ltd,
Published by
PharmiWeb.com
07 Jul 09 Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn Amgen,
Published by
PharmiWeb.com
07 Jul 09 Novartis extends tuberculosis drug donation to Tanzania Novartis,
Published by
PharmiWeb.com
06 Jul 09 LILLY RECEIVES FOURTH FDA APPROVAL FOR ALIMTA (pemetrexed for injection) Eli Lilly and Company
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.